Image of mining activity.
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Mining giant Fortescue Ltd (ASX:FMG) told investors that a strong record for iron ore shipments had propelled the company to its third highest earnings in history during the 2024 fiscal year.

FMG’s underlying EBITDA (earnings before interest, taxes, depreciation, and amortization) came in at US$10.7 billion – a 7% rise from FY23 – reflecting iron ore shipments of 191.6 million tonnes (Mt) during the same period.

The company also reported a net profit after tax (NPAT) of US$5.7 billion, plus earnings per share of US$1.85 (A$2.82).

Chief Executive Officer Dino Otranto said FY24 had been a year of achievements for FMG.

“The team has delivered another year of outstanding performance contributing to the third highest earnings in Fortescue’s history and free cash flow of US$5.1 billion,” he said.

“We celebrated a number of significant milestones including first ore from the Flying Fish and Hall Hub deposits as well as the commissioning of our gaseous and liquid hydrogen plant which is the largest of its kind on a mine site in Australia.

“We will use the hydrogen from this plant for our Green Metal Project, which we commenced works on earlier this month.

“Reflecting our ongoing commitment to delivering shareholder returns, the Board has declared a fully franked final dividend of A$0.89 per share, bringing total dividends declared for FY24 to A$1.97 per share. This represents a 70 per cent payout of net profit after tax.”

FMG shares rose half a percent on the news. At 10:48 AEST, they were trading at $18.72, a rise of 0.48% since the market opened.

fmg by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…